Counterpoint Mutual Funds
BSX icon

Counterpoint Mutual Funds’s Boston Scientific BSX Stock Holding History

Counterpoint Mutual Funds’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$632K Buy
+14,473
New +$670K 0.05% 135
2026
Q2 		– Sell
-4,016
Closed -$252K – 312
2026
Q1 		$252K Sell
4,016
-1,264
-24% -$101K 0.04% 280
2025
Q4 		$503K Buy
5,280
+2,176
+70% +$213K 0.04% 136
2025
Q3 		$303K Buy
+3,104
New +$321K 0.02% 308
2023
Q2 		– Sell
-1,804
Closed -$90.3K – 317
2023
Q1 		$90.3K Buy
+1,804
New +$85K 0.08% 302

Other funds holding BSX

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Counterpoint Mutual Funds's BSX Position: Q3 2026 in Review

Counterpoint Mutual Funds opened a new position in Boston Scientific (BSX) in Q3 2026: 14,473 shares worth $632K. The stake represents 0.05% of the portfolio and ranks #135 among its holdings. This is a return to the name: Counterpoint Mutual Funds previously reported a position in BSX as recently as Q1 2026.

Counterpoint Mutual Funds first reported a position in BSX in Q1 2023 and has held it in 5 quarters since. 954 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Counterpoint Mutual Funds held 14,473 shares of Boston Scientific worth $632K as of Q3 2026.
  • Boston Scientific was a new Counterpoint Mutual Funds position in Q3 2026.
  • Boston Scientific made up 0.05% of Counterpoint Mutual Funds's portfolio in Q3 2026, its #135 holding.
  • Counterpoint Mutual Funds first reported a position in Boston Scientific in Q1 2023 and has held it in 5 quarters since.
  • 954 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q3 2026, filed 16 Oct 2026.